Article info

PDF

Extended report
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study

Authors

  1. Correspondence to Professor Désirée van der Heijde, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands; mail{at}dvanderheijde.nl
View Full Text

Citation

van der Heijde D, Deodhar A, Wei JC, et al
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study

Publication history

  • Received August 5, 2016
  • Revised November 24, 2016
  • Accepted November 26, 2016
  • First published January 27, 2017.
Online issue publication 
July 11, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.